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Induction of Emphysematous Lesions in Rat Lung by ß-D-xyloside, an Inhibitor of Proteoglycan Synthesis Toin H. van Kuppevelt, Chris H. A. van de Lest, Elly M. M. Versteeg, P. N. Richard Dekhuijzen, and Jacques H. Veerkamp
Departments of Biochemistry and Pulmonary Diseases, University of Nijmegen, Nijmegen, the Netherlands
The possible involvement of proteoglycans in the pathogenesis of emphysema was studied in rats by a sin gle intratracheal instillation of /?-nitrophenyl-j9-D-xylopyranoside (jS-D-xyloside), an inhibitor of pro teoglycan synthesis. The first 3 days after instillation are characterized by mild hemorrhages, some infiltra tion of inflammatory cells, and edema. After 1 wk, lung morphology is normal again. Forty days after instillation, considerable parenchymal destruction has occurred as determined by the mean linear intercept (81 ± 12 ¿uni versus 57 ± 5 ¡xm for control [P < 0.001J). Pulmonary fibrosis is not observed. Instillation with /7-nitrophenyl-o:-D-xylopyranoside and p-nitrophenol do not induce parenchymal destruction, indi cating the specificity of /5-D-xyloside action. Urinary glycosaminoglycan (GAG) content of the /3-Dxyloside-treated rats is increased 15-fold during the first day after instillation, mainly due to elevated levels of chondroitin sulfate and dermatan sulfate. The increase is correlated to the extent of parenchymal de struction after 40 days (r = 0.68; P < 0.002). At day 2 and thereafter, levels are normal again. A short-term increase in dermatan and chondroitin sulfate content is also observed in serum, bronchoalveolar lavage (BAL) fluid, and lung tissue. Heparan sulfate content is decreased in BAL fluid and lung tissue. Instillation with /?-nitrophenyl-a:-D-xylopyranoside and /7-nitrophenol do not induce elevated GAG concentration in urine. We suggest that a disturbance in proteoglycan synthesis accompanied by an increase of (|3-Dxyloside-primed) free GAGs results in loss of stability and integrity of the alveolar wall, leading to paren chymal destruction and emphysematous lesions. |3-D-xyloside treatment may be an alternative experimen tal method for inducing emphysema, van The predominant theory on the pathogenesis of emphysema pear to be complex and other macromolecules of the alveis contained in the protease/antiprotease concept (1) (2) (3) . A olar wall should be considered. A major component in the relative surplus of proteases causes degradation of the al veo-nonfibrillar part of the extracellular matrix of alveoli is prolar elastic fiber matrix, leading to a destruction of the alveo-teoglycans. Proteoglycans consist of a core protein to which lar walls. Elastin degradation is believed to be pivotal in this one or more strongly negatively charged glycosaminoglycan (GAG) side chains are covalently attached. In the alveolar wall several proteoglycans are present including heparan sul fate proteoglycans (e.g., the basement membrane-associated perlecan and the cell membrane-associated syndecans) and collagenase (7) . Thus the causes of alveolar destruction ap-dermatan/chondroitin sulfate proteoglycans (e.g., the colla gen fibril-associated decorin, and biglycan) (8) . Several characteristics of proteoglycans make them likely candidates for playing a key role in the maintenance of the /996) structural integrity of the alveolar wall. They interact with 76 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY VOL. 16 1997 dition, the close association of proteoglycans with structural elements in the alveolar wall (e.g., basement membranes, collagen fibrils, and elastic fibers) indicates a structural role.
Since the structural integrity of alveoli is compromised in emphysema, alterations in the proteoglycan composition should be considered as a factor contributing to the patho genesis of emphysema. Proteoglycans have been almost en tirely neglected in studies on emphysema (24). Previously we showed that proteoglycans are target molecules for pan creatic elastase instilled into rat lung (25) . Now, to eval uate the importance of proteoglycans in alveolar wall stabil ity and in the pathogenesis of emphysema, we studied the effect of a single intratracheal instillation of /?-nitrophenyl-/3-D-xylopyranoside (j8-D-xyloside), which is an inhibitor of proteoglycan synthesis (26) . As control agents we ap plied /j-nitrophenyl-a-D-xyloside (a-D-xyloside) and /7-nitrophenol. The a-D-xyloside does not change proteoglycan synthesis via the false acceptor pathway, in contrast to the 0-D-xyloside, and can be used to discern between the pro teoglycan synthesis-disturbing effect of jS-D-xyloside and other effects (27) . vol % dimethyl sulfoxide (DMSO) in 0.14 M NaCl; 0.5 ml
Materials and Methods
1,9-DimethyImethylene blue (DMMB) (80% pure) was pur chased from Aldrich Chem. Co. (Bornem, Belgium); Uni versal Gel/8 1% agarose gels from Ciba-Corning GMBH (Fernwald, Germany); halothane from Apharmo (Arnhem, the Netherlands); pentobarbital (Narcovet) from ICI-Farma (Rotterdam, the Netherlands); diethylaminoethyl (DEAE)-Sepharose Fast Flow from Pharmacia (Uppsala, Sweden); ;?-nitrophenol, aquamount, and cetyl-trimethyl-ammoniumbromide from BDH Ltd. (Poole, UK); and Azure A, Tween-20, whale cartilage chondroitin 4-sulfate, bovine kidney heparan sulfate, porcine pancreatic elastase, bovine serum albumin (BSA), ¿3-D-xylopyranoside, a-D-xylopyranoside, Ar-methylsuccinyl-ala-ala-pro-val7-amino-4-methyl-coumarin, fluoresceinisothiocyanate-conjugated goat antimouse IgM, and mouse antichondroitin sulfate (clone CS-56) from Sigma Inc. (St. Louis, MO). Mouse monoclonal antiheparan sulfate (JM403) antibody was obtained and characterized as described (28) .
P5SJGAGs (specific activity 6 X 10' Bq//zg GAG) were twice i.p. with 37,000 Bq 40 niM j3-D-xyloside (20 /xmol) in 0.14 M NaCl; 0.5 ml 50 mM a-D-xyloside (25 ¿imol) in 10 vol % DMSO in 0.14 M NaCl; 0.5 ml 100 mM /?-nitrophenol (50 /¿mol) in 10 vol % DMSO in 0.14% NaCl; 0.5 ml porcine pancreatic elastase obtained from rats Nay'sSO.i/g body weight with a 4-h time span between in jections. Four hours after the second injection the rats were killed and the soft tissues (i.e., liver, kidney, intestine, etc.) removed. GAGs were extracted by alkaline borohydride (29) .
Animal Accommodation
Rats were accommodated in groups of three and fed ad lib.
For urine collection, they were accommodated separately in metabolic cages. To avoid stress factors, rats were habituated to these cages for 7 days before treatment.
I ntratracheal Instillation
Male Wistar rats (200 ± 10 g) were anesthetized with 3% halothane, intubated, and artificially respirated according to Mauderly (30) . Rats were hyperventilated to stop breathing lor a few seconds, and were instilled during this time span Isolation of GAGs from Serum with either 0.5 ml 200 mM /3-D-xyloside (100 ¿imol) in 10
To 100 n 1 serum, 8 /¿I trichloroacetic acid solution (1 g/ml) (0.2 IU/g body weight) in 0.14 M NaCl; 0.5 ml 10% DMSO in 0.14 M NaCl; or 0.5 ml 0.14 M NaCl. Maximal doses of a-D-xyloside and p-nitrophenol were applied (25 and 50 /jmol, respectively); higher doses were lethal. All solutions were administered at 37°C. After instillation, rats were res pirated until they awoke.
Histology
Animals were killed by an overdose of pentobarbital injected i.p. For morphometric studies, lungs were dissected and fixed with 2% formaldehyde in 150 mM phosphate buffer (pH 7.2) administered through a polyethylene catheter in serted into the trachea at a pressure of 25 cm H,0. After 30 min, lungs were fixed for an additional 24 h in 4% formal dehyde, dehydrated, and embedded in paraffin. Tissue sec tions (6 ¡xm) were contrasted using the trichrome staining method of Goldner (31) . To assess the degree of air-space en largement, the mean linear intercept (MLI) was determined using a Mop-videoplan image analyser (Kontron GMBH, Eching, Miinchen, Germany).
For immunofluorescence and biochemical studies, lungs were dissected and inflated through the trachea with 5 ml phosphate-buffered saline (PBS) (pH 7.2). PBS-filled lungs were frozen in liquid nitrogen and stored at -70°C. Cryosections (6 /¿m) were rehydrated for 10 min in PBS, containing 1% BSA. Antibodies were applied for 1.5 h in PBS contain ing 1% BSA. After each antibody incubation, sections were washed in PBS (3 times for 5 min). Antiheparan sulfate anti bodies and all secondary antibodies were used at a dilution of 1:100. All other antibodies were used at 1:50. Sections were embedded in aquamount and examined on a Zeiss axioskop photomicroscope (Carl Zeiss, Oberkochen, Germany).
Isolation of GAGs from Urine and BAL Fluid
Bronchoalveolar lavage (BAL) fluid was obtained from the left lung by washing the dissected lung once with 4 ml and 4 times with 2 ml PBS (4°C). Cells were removed from BAL fluid by centrifugation (1,000 x g, 10 min, 4°C). The total yield of BAL fluid was 10 ml.
Rat urines were collected 1 day before to 7 days after in stillation (each day). Urine was centrifuged at 2,000 X # for 10 min (4°C), and 20 ml of the supernatant was diluted to 50 ml by adding 10 mM Tris-HCl (pH 6.8).
GAGs were purified from urine and BAL fluid by anion exchange chromatography as described (25) . Urine samples (50 ml) or BAL fluids (7 ml) were loaded onto a column of 5 X 0.5 cm containing 0.5 ml DEAE-Sepharose Fast Flow. After an initial wash with 3 ml 0.2 M NaCl/10 mM Tris-HCl (pH 6.8), GAGs were eluted with 1 ml 2 M NaCl/10 mM Tris-HCl (pH 6.8) followed by 3 ml 10 mM/Tris-HCl (pH 6.8). Recovery of urinary GAGs was monitored by adding 9 X 105 Bq [^SJGAG to the urine sample and was between 72 and 101%. was added. After centrifugation for 20 min at 10,000 X g , nium-bromide was added. After 5 min preincubation at the supernatant was removed and stored on ice. The protein 37°C, 5 fx 1 substrate solution (10 mM /V-methylsuccinyl-alabound GAGs were liberated from the pellet by /3-elimination ala-pro-val7-amino-4-methyl-eoumarin dissolved in DMSO) as follows. The pellet was suspended in 100 ¡x\ 0.75 M NaOH/50 mM NaBH4 and incubated for 1 h at 73°C. After 1 h the mixture was cooled on ice and neutralized with 6 M was added. Fluorescence was monitored on a Shimadzu RF-5000 spectrofluorometer at excitation and emission wave lengths of 375 and 440 nm, respectively. Human leukocyte HC1. The remaining proteins were removed by addition of elastase, a generous gift of Dr. J. Schalkwijk (Department 9 ¡x1 trichloroacetic acid solution (I g/ml) and centrifugation of Dermatology, University of Nijmegen), was taken as a (20 min, 10,000 x g). The supernatants of both precipita tions were pooled and 5 vol of 100% ethanol were added. Alter 16 h at -20°C the mixture was centrifuged for 30 min standard.
Statistical Analysis at 15,000 x g (0°C), and the precipitated GAGs were dried, Intergroup comparison was calculated using Student's / test, dissolved in 50 ¡x\ 50 mM barium acetate (pH 5.0)/40% Correlation analysis was performed using Pearson's product glycerol/0.01 % bromophenol blue, and subjected to agarose moment correlation test (36) . All values are given as mean gel electrophoresis (see below).
± SD.
Isolation of GAGs from Parenchymal Lung Tissue
GAGs were extracted according to a modified method of Hoffman (29) . Pleura, large airways and blood vessels were removed from 30-ju.m-thick cryosections. The remaining tis sue was lyophilized, weighed, and suspended in 200 ¡xl 0.75 M NaOH/lO mM NaBH4. After 1 h at 73°C, the mixture was neutralized with 6 M HC1 and trichloroacetic acid was added to a final concentration of 60 mg/ml. After 1 h at 4°C
and centrifugation for 15 min at 2,000 x g (4°C), the pellet was dissolved in 100 ¡x\ 100 mM NaOH and the protein con centration determined according to Lowry and colleagues (32) . To the GAGs-containing supernatant, 5 vol of 100% ethanol were added and after 16 h at -20°C the mixture was centrifuged (30 min, 15,000 X g , 4°C). The precipitated GAGs were dried and dissolved in demineralized water.
Quantification of GAGs by Gel Electrophoresis
GAG samples from urine, BAL fluid, serum, and lung tissue were separated on agarose gel using 0.05 M barium acetate (pH 5.0) as electrophoresis buffer. GAGs were visualized using a combined azure A/silver staining as described, and quantified by densitometric analysis (33) . The nature of the GAGs was established by specific degradation procedures: nitrous acid for heparan sulfate, chondroitinase ABC diges tion for chondroitin sulfate and dermatan sulfate, and chon droitinase AC digestion for chondroitin sulfate (33) .
Quantification of Sulfated GAGs by a Spectrophotometric Assay
The content of sulfated GAGs was determined using the DMMB assay of Farndale and associates (34) . To a 100-/J GAG sample, 2.5 ml of DMMB-reagent was added and the absorbance at 525 nm was measured directly. The DMMBreagent consists of 48 /¿M DM M B (initially 48 jumol DMMB was dissolved in 5 ml 96% ethanol), 42 mM glycine, and 42 mM NaCl, adjusted to pH 3.0 with 1 M HC1. Chondroitin 4-sulfate was taken as a standard and included within each series of assays.
Determination of Elastase in BAL Fluid
Elastase activity was determined using the fluorogenie sub strate /V-methylsuccinyl-ala-ala-pro-val 7-amino-4-methylcoumarin according to Castillo 
Results

General Morphology
Three hours after intratracheal instillation of 100 nmol (3-D-xyloside, mild hemorrhages and some infiltration of inflammatory cells are observed in the lung. These phe nomena subside 3 days after instillation and lung morphol ogy returns to normal after 1 wk. The extent of hemorrhages and infiltration of inflammatory cells is much less pro nounced compared to elastase-treated animals ( Figure 1 ). Animals instilled with a-D-xyloside, /j-nitrophenol, 10% DMSO, or physiologic salt display less hemorrhages and inflammation than /3-D-xyloside-treated rats. Edema is ob served in bronchioli, blood vessels, and alveolar walls until day 5 after /3-D-xyloside instillation, whereas other animals display only some edema in bronchioli and large blood ves sels during the first 2 days. Forty days after treatment, parcnchymal destruction is in /3-D-xyloside-treated animals ( Figure 2 ), as determined by an increase of the MLI to 81 ± 12 ¡Xm (n = 11) ( Figure 3 ). The MLI is the average distance between two alveolar septa and is a parameter of air-space enlargement. Occasionally very severe parenchy mal destruction is present ( Figure 2c ). Fibrosis is not ob served. The extent of /3-D-xyloside-induced parenchymal destruction is comparable to that induced by pancreatic elastase (MLI: 82 ± 11 ixm \n = 12] versus 59 ± 4 ¿un |/¿ for control, Figure 3 (Figure 4b) , which changes to a more distinct staining pattern 3 to 7 days after treatment (Figure 4c ). Phase contrast microscopy indicates a colocalization of chondroitin sulfate staining with fiberlike structures, presumably elastic fibers (Figures 4c and  4d ). Colocalization of chondroitin sulfate staining with these structures can also be observed in alveoli 2 to 14 days after pancreatic elastase treatment (data not shown). ? Heparan sulfate staining was found linearly distributed in the alveolar wall, in accordance with its presence in base ment membranes. No obvious alterations in heparan sulfate staining could be detected in /3-D-xyloside-treated rats (Fig  ure 5 ). The distance between the two opposite alveolar base ment membranes in the alveolar wall, visualized by heparan sulfate staining, is increased ( Figure 5 ). This indicates the presence of edema in the alveolar wall ( Figure 5 ).
GAGs in Urine, Serum, BAL Fluid, and Lung
Since /3-D-xyIoside acts as an artificial initiator of GAG syn thesis and could cause an increase in the synthesis of free GAGs (26), we examined the amount and composition of GAGs in BAL fluid, serum, urine, and lung tissue.
In the urine of rats instilled with 100 ¿imol /3-xyloside, a 15-fold increase in GAG content is observed at day 1, whereas in rats instilled with 20 /xmol a 13-fold increase is noted (Table 1) . cx-D-xyloside and/?-nitrophenol-treated rats do not show an increase of GAG excretion (Table 1) . At day 2 and thereafter, urinary GAG levels become normal again in (8-D-xyloside-treated rats. The increase in urinary GAG can be allotted mainly to an increase in dermatan sulfate and chondroitin sulfate, as was determined by agarose gel elec- *P < 0.001.
trop ho res is ( Figure 6) . A significant correlation is found be tween the increase of urinary GAG content the first day after treatment, and the extent of air-space enlargement (MLI) de veloped after 40 days (Figure 7 ). In serum, dermatan sulfate and chondroitin sulfate are in creased during the first two days after treatment ( Table 2) . Heparan sulfate, which constitutes only 0.3% of serum GAGs (32), was not analyzed.
BAL fluid shows the most complex alterations in GAG content and composition (Table 3 ). The major GAG in BAL fluid from control animals is heparan sulfate, whereas chon droitin sulfate and dermatan sulfate are minor components. One hour after /3-D-xyloside treatment, dermatan sulfate and chondroitin sulfate contents are dramatically increased, which is even more evident after 3 h. One day after treatment chondroitin sulfate migrates as a narrow band, indicating less heterogeneity in charge and/or size, while dermatan sul fate is separated into two distinct bands. Heparan sulfate content is significantly decreased at day I and is further reduced 2 days after treatment. Chondroitin sulfate has re turned to control values at day 2. The nature of the GAGs, which was determined by agarose gel electrophoresis, was confirmed by enzymatic digestion (data not shown).
Analysis on cryosections of parenchymal lung tissue showed that dermatan sulfate and chondroitin sulfate are in creased at 3 h and 1 day, and at 1 day after treatment, respec tively, while the heparan sulfate content is significantly de- i . 39.6 ± 4.0 (5) 41.5 ± 6.0 (9) n. d . n.d. n, d . 7
' :
40.9 ± 6.4 (5) 42.9 ± 5.9 (9) n.d. n . d . n.d.
Values are expressed a: creased 2 days after treatment ( Table 4 ). All values return to control levels 7 days after treatment.
Elastase Activity in BAL Fluid
In /3-D-xyloside-treated rats, BAL fluid shows a modest in crease in elastase activity one day after treatment (3.2 ± 0.6 [n 3] versus 2.1 ± 0.4 ng /ml BAL fluid for control [10% DMSO, n = 6 ] ) . Levels are normal the second day.
Discussion
In this study we show that intratracheal instillation of 100 /xmol /3-D-xyloside in rats induces the development of em physematous lesions. After treatment with 20 /xmo 1 /3-D-xylo side only about 30% of the animals developed emphysema tous lesions, indicating a dose-dependent effect of the drug. a-D-xyloside and the aglycon p-nitrophenol do not induce emphysematous lesions, indicating that the effect is specific for /3-D-xyloside. /3-D-xyloside mimics the serine-xyloside GAG initiation site of the core protein of proteoglycans, and competes as a false acceptor for GAG synthesis (26) . Ad ministration of /3-D-xyloside, but not «-D-xyloside or/>-nitrophenol, increases GAG synthesis, which is particularly evi dent from the 15-fold increase of GAG content in the urine of treated rats. The increase comes mainly to the account of chondroitin and dermatan sulfates, which is typical for the /3-D-xyloside preparation we used (/?-nitrophenyl-/3-D-xylopyranoside) (37) . The strong increase of urinary GAG con tent cannot be attributed solely to an increase in the synthesis of GAGs in the lung. Other organs, which possibly receive a dose of /3-D-xyloside indirectly through the blood, may also contribute. This especially applies to the kidney, since the GAG content in serum showed only a 2-lbld increase compared to the 15-fold increase in urine. In an organ perfu sion system, 2.5 mM /3-D-xyloside stimulated the synthesis of chondroitin sulfate and dermatan sulfate in glomeruli (38) . The amount of increase in urinary GAG content 1 day after treatment is positively correlated to the extent of paren- corneal stroma, which leads to a reduced synthesis of dermatan sulfate proteoglycans but an increase in free dermatan sulfate, resulted in a reduced collagen fibril packing and a disruption of lamellar organization (41) . The situation may be somewhat analogous to cervical dilatation at the end of pregnancy, a process which is accompanied by a dramatic in crease in collagen-associated dermatan sulfate (42, 43) . An increase of chondroitin sulfate content can impair elastic fiber assembly by inhibition of the binding of the 67 kD elastin-binding protein to elastic fibers and the cell mem brane (44) . GAGs may further disturb repair of the alveolar matrix since they are potent inhibitors of lysyl oxidase (45) , an enzyme crucial for the cross-linking of collagen and clas* tin. Ex vivo treatment of mouse embryos with /3-D-xyloside inhibited branching morphogenesis in the lung (46) . Avail ability of growth factors may also be affected by the increase in GAGs; /3-D-xyloside-primed GAGs are able to bind chymal destruction observed at day 40. This indicates that growth factors, as do GAGs in proteoglycans (47) , All these the degree of disturbance in the lung during the initial phase effects will compromise the delicate balance of alveolar wall of the insult determines the degree of parenchymal destruc-homeostasis and prevent an orderly repair, finally resulting tion in a later phase.
Although the mechanism of the parenchyma] destruction due to /3-D-xyloside treatment is not clear, it is likely medi-in parenchymal destruction and emphysematous lesions
In 0-D-xyloside-treated rats only mild hemorrhages and inflammation were observed in the lung, in contrast to pancre ated by the increase in synthesis of free GAGs and the con-atic elastase-treated animals (Figure 1 ) (25) . This could be comitant decrease in proteoglycan synthesis. In BAL fluid an effect of DMSO which was used as a solvent for/3-D-xyioand parenchymal lung tissue we found an increase in total side. DMSO acts as an anti-inflammatory agent and is a GAG content due to an increase in dermatan and chondroitin scavenger of free radicals (48) . The increase in free elastase sulfates, but heparan sulfate was decreased. We did not ob-activity measured in the BAL fluid is only moderate. Apart serve a clear decrease in heparan sulfate proteoglycans of from the mild infiltration of inflammatory cells, this may the alveolar basement membrane using immunofluores-also be an effect of the increase in GAGs which arc cence. Others, however, found a 25% decrease in basement inhibitors of neutrophil elastase (14, 15) . Hemorrhages and membrane proteoglycans (predominantly heparan sulfate inflammation may not play an important role in alveolar tisproteoglycans) with ruthenium red staining in mouse sub sue degradation in ß-D-xyloside-treated rats. The total free mandibular salivary glands (39) . A 43% decrease in hep-elastase activity in BAL fluid is 64 ng/rat, which stands aran sulfate synthesis, together with a 4-fold increase in chon small compared to the amount of neutrophil elastase neces droitin sulfate synthesis was observed after 0-D-xyloside sary to induce pulmonary emphysema by intratracheal instiltreatment of the basement membrane producing EHS (Engel-lation (about 300 jug neutrophil elastase 149)). However, breth-Holm-Swarm) tumor in vitro (40) . Basement mem some damage to the alveolar wall due to inflammation and brane heparan sulfate proteoglycan is believed to function as neutrophil elastase cannot be excluded. a charge barrier for proteins. A probable loss of heparan sul fate proteoglycans together with an increase in total GAGs, The importance of proteoglycans in the stability of the lung parenchyma has recently been demonstrated. Intrawhich possess high water-binding properties, may account trachéal instillation of testicular hyaluronidase (which defor the observed edema in the treated rat lungs. grades hyaluronate and dermatan sulfate and chondroitin The observed increase in dermatan and chondroitin sul-sulfate) followed by exposure to a nontoxic concentration of fates content may destabilize collagen fibrils and reduce their oxygen (60% ) results in a significant air-space enlargement tensile strength. /5-D-xyloside treatment of developing avian in hamster lungs (50) . Hyaluronidase instillation also aug- ments pancreatic elastase-induced parenchymal destruction (5 1). We showed an increase of urinary GAGs and a decrease of lung GAGs and heparan sulfate proteoglycans shortly after pancreatic elastase instillation into rat lungs (25) . The uri nary GAG content correlated also to the extent of emphy sema developed after 40 days.
TABLK3
Effect of intratracheal instillation of 100 /xmoI ß-D-xyloside on heparan sulfate (HS) , dermatan sulfate (DS), and chondroitin sulfate (CS) content in BAL fluid o f rats
In conclusion, a single intratracheal instillation of a high dose of /3-D-xyloside results in the development of em physematous lesions. This effect is likely mediated by the short-term increase of free GAG chains (and possibly the de crease of proteoglycan content). It underscores the impor tance of proteoglycans in alveolar wall integrity and indi cates their involvement in the pathogenesis of emphysema. /3-D-xyloside treatment may be an alternative experimental way to induce emphysema. The detrimental effect of /3-D-xylo side on the lung should be taken into consideration when evaluating /3-D-xyloside preparations as antithrombotic drugs (52) .
